Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000239

EVP, Chief Scientific Officer sold 20,536 shares at an average $84.95 ($1,744,623)

  • EVP, Chief Scientific Officer acquired 15,000 shares (other)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BENNETT C FRANK · EVP, Chief Scientific Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-07-07 Sale : show line 1 in the form 10b5-1 −5,536 $83.58 $462,693 75,018 D
2026-07-07 Other acquisition : show line 2 in the form 10b5-1 +15,000 15,000 I
2026-07-07 Sale : show line 3 in the form 10b5-1 −15,000 $85.46 $1,281,930 0 I
Open-market sales · 20,536 sh · avg $84.95 · $1,744,623

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-07-07 Other disposition : show line 4 in the form 10b5-1 Restricted Stock Unit −15,000 12,109 D
Loading xslF345X06/edgardoc.xml…